Table 1 Metaplasia of the normal and pathological endometrium
From: Eosinophilic cell change of the endometrium: a possible relationship to mucinous differentiation
Type of the lesion | Total | Ciliated | Mucinous | Eosino | Squ/morl | Syn | Arias |
|---|---|---|---|---|---|---|---|
Benign nonhyperplastic endometrium | 39 | 20 (51%) | 3 (8%) | 4 (10%) | 0 | 0 | 1 (3%) |
Normal proliferative phase | 4 | 4 (100%) | 1 (25%) | 1 (25%) | 0 | 0 | 0 |
Normal secretory phase | 4 | 0 | 0 | 0 | 0 | 0 | 1 (25%) |
Abnormal cycling endometrium | 7 | 2 (29%) | 0 | 1 (14%) | 0 | 0 | 0 |
Atrophic endometrium | 5 | 4 (80%) | 0 | 1 (20%) | 0 | 0 | 0 |
Endometrial polyp | 11 | 7 (64%) | 2 (18%) | 1 (9%) | 0 | 0 | 0 |
Adenomyosis | 5 | 1 (20%) | 0 | 0 | 0 | 0 | 0 |
Polypoid adenomyoma | 3 | 2 (67%) | 0 | 0 | 0 | 0 | 0 |
Endometrial hyperplasia | 14 | 6 (43%) | 1 (7%) | 7 (50%) | 1 (7%) | 2 (14%) | 0 |
Simple nonatypical hyperplasia | 6 | 6 (100%) | 0 | 3 (50%) | 0 | 2 (33%) | 0 |
Complex nonatypical hyperplasia | 3 | 0 | 0 | 2 (67%) | 0 | 0 | 0 |
Complex atypical hyperplasia | 5 | 0 | 1 (20%) | 2 (40%) | 1 (20%) | 0 | 0 |
Endometrial carcinoma | 42 | 3 (7%) | 21 (49%) | 16 (37%) | 6 (14%) | 0 | 0 |
Endometrioid adenocarcinoma (G1) | 32 | 3 (10%) | 16 (50%) | 13 (41%) | 6 (19%) | 0 | 0 |
Endometrioid adenocarcinoma (G2) | 4 | 0 | 2 (50%) | 2 (50%) | 0 | 0 | 0 |
Mucinous adenocarcinoma | 3 | 0 | 3 (100%) | 0 | 0 | 0 | 0 |
Serous adenocarcinoma | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
Total lesions | 95 | 29 (31%) | 25 (26%) | 27 (28%) | 7 (7%) | 2 (2%) | 1 (1%) |
